Andrew Anderson
Job title:
Areas of work:
- Process Analytical Technology (PAT) strategy, deployment and technology integration in pharmaceutical manufacturing
- Implementation of advanced analytics, automation, and novel technologies such as terahertz and AI for drug development and commercial production
- Technology scouting, innovation management, and driving cross-functional partnerships across government, academia, and industry
- Enhancing manufacturing efficiency, data integrity, and regulatory compliance through digital transformation and Quality by Design (QbD) principles. Continuous direct compression specialist for OSD
- Process optimization and integration support
Detailed Bio
Andrew Anderson is the Founder and Principal Consultant at ASquared Consultancy, specializing in Process Analytical Technology (PAT) and digital innovation in the pharmaceutical and life sciences sectors. With over 20 years of experience, he has a strong background in implementing PAT frameworks, advanced analytics, and data-driven manufacturing process improvements to enhance quality and compliance.
Previously, Anderson held critical roles at Johnson & Johnson and GlaxoSmithKline (GSK), where he led PAT strategy, deployment, and technology integration projects. At these global pharmaceutical leaders, he contributed to the modernization of manufacturing processes through real-time analytics, Quality by Design (QbD), and continuous improvement initiatives. His work focused on bridging scientific innovation with operational execution to optimize drug development and commercial production.
Known for his strategic vision and collaborative approach, Anderson continues to drive transformative PAT adoption and technological advancement through consultancy, helping organizations achieve regulatory compliance and operational excellence in biopharma manufacturing.
Presentations at events
TTC – Process Analytical Conference 2026
Presentation Title: The importance of an end-to-end PAT strategy